Product Name
TREM-2b (Trem2), Monoclonal Antibody
Full Product Name
TREM-2b (Trem2b, Triggering Receptor Expressed on Monocytes 2)
Product Synonym Names
Anti -TREM-2b (Trem2b, Triggering Receptor Expressed on Monocytes 2)
Product Gene Name
anti-Trem2 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 17; NC_000083.6 (48346401..48352273). Location: 17 C; 17
3D Structure
ModBase 3D Structure for Q99NH8
Specificity
Purified by Protein G affinity chromatography. Does not crossreact with rmTREM-1, rhTREM-2, or rmTREM-3.
Purity/Purification
Affinity Purified
Purified by Protein G affinity chromatography.
Form/Format
Supplied as a lyophilized powder from a 0.2um filtered solution in PBS, 5% trehalose. Reconstitute with 1ml sterile ddH2O or sterile 40-50% glycerol.
Immunogen
NS0-derived recombinant mouse Triggering Receptor expressed on Myeloid cells 2b extracellular domain
Preparation and Storage
Lyophilized powder may be stored at 4 degree C for short-term only. Reconstitute to nominal volume by adding sterile 40-50% glycerol and store at -20 degree C. Reconstituted product is stable for 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Other Notes
Small volumes of anti-Trem2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Product Categories/Family for anti-Trem2 antibody
Antibodies; Abs to Receptors
Applications Tested/Suitable for anti-Trem2 antibody
ELISA (EL/EIA), Western Blot (WB)
Application Notes for anti-Trem2 antibody
Suitable for use in ELISA and Western Blot.
Dilution: ELISA: 0.5-1ug/ml
Western Blot: 1-2ug/ml
NCBI/Uniprot data below describe general gene information for Trem2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001259007.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001272078.1
[Other Products]
UniProt Primary Accession #
Q99NH8
[Other Products]
UniProt Secondary Accession #
Q8CGK4; Q8CIA6; Q99NH9; Q9JL34[Other Products]
UniProt Related Accession #
Q99NH8[Other Products]
Molecular Weight
24,527 Da[Similar Products]
NCBI Official Full Name
triggering receptor expressed on myeloid cells 2 isoform 2
NCBI Official Synonym Full Names
triggering receptor expressed on myeloid cells 2
NCBI Official Symbol
Trem2 [Similar Products]
NCBI Official Synonym Symbols
TREM-2; Trem2a; Trem2b; Trem2c
[Similar Products]
NCBI Protein Information
triggering receptor expressed on myeloid cells 2; triggering receptor expressed on monocytes 2; triggering receptor expressed on myeloid cells 2a; triggering receptor expressed on myeloid cells 2b; triggering receptor expressed on myeloid cells 2c
UniProt Protein Name
Triggering receptor expressed on myeloid cells 2
UniProt Synonym Protein Names
Triggering receptor expressed on monocytes 2
Protein Family
Triggering receptor expressed on myeloid cells
UniProt Gene Name
Trem2 [Similar Products]
UniProt Synonym Gene Names
Trem2a; Trem2b; Trem2c; TREM-2 [Similar Products]
UniProt Entry Name
TREM2_MOUSE
NCBI Summary for Trem2
The protein encoded by this gene is part of the immunoglobulin and lectin-like superfamily and functions as part of the innate immune system. This gene forms part of a cluster of genes on mouse chromosome 17 thought to be involved in innate immunity. This protein associates with the adaptor protein Dap-12 and recruits several factors, such as kinases and phospholipase C-gamma, to form a receptor signaling complex that activates myeloid cells, including dendritic cells and microglia. In humans homozygous loss-of-function mutations in this gene cause Nasu-Hakola disease and mutations in this gene may be risk factors to the development of Alzheimer's disease. In mouse mutations of this gene serve as a pathophysiological model for polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (Nasu-Hakola disease) and for inflammatory bowel disease. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Jan 2013]
UniProt Comments for Trem2
TREM2: May have a role in chronic inflammations and may stimulate production of constitutive rather than inflammatory chemokines and cytokines. Forms a receptor signaling complex with TYROBP and triggers activation of the immune responses in macrophages and dendritic cells. Defects in TREM2 are a cause of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL); also known as presenile dementia with bone cysts or Nasu-Hakola disease (NHD). PLOSL is a recessively inherited disease characterized by a combination of psychotic symptoms rapidly progressing to presenile dementia and bone cysts restricted to wrists and ankles. PLOSL has a global distribution, although most of the patients have been diagnosed in Finland and Japan, with an estimated population prevalence of 2x10(-6) in the Finns. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: Membrane protein, integral
Cellular Component: intracellular membrane-bound organelle; membrane; plasma membrane; integral to membrane; extracellular region
Molecular Function: protein binding; peptidoglycan binding; transmembrane receptor activity; lipopolysaccharide binding
Biological Process: positive regulation of peptidyl-tyrosine phosphorylation; detection of lipopolysaccharide; detection of peptidoglycan; lipopolysaccharide-mediated signaling pathway; innate immune response; positive regulation of calcium-mediated signaling; signal transduction; positive regulation of antigen processing and presentation of peptide antigen via MHC class II
Research Articles on Trem2
1. Trem-2 plays an important role in the host defense response to sepsis by enhancing bacterial clearance.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.